A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
about
Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition.The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium.Role of extracellular matrix in breast cancer development: a brief update.
P2860
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
@en
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
@nl
type
label
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
@en
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
@nl
prefLabel
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
@en
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
@en
P2093
Alexandra Matzge-Ogi
Bogdan-Tiberius Preca
Karolina Bajdak
Kerstin Mock
Marc P Stemmler
Peter Bronsert
Simone Brabletz
Thomas Brabletz
Vignesh Sundararajan
Waltraut Lehmann
P2860
P304
11530-11543
P356
10.18632/ONCOTARGET.14563
P407
P577
2017-01-09T00:00:00Z